Skip to main content

File #: 2025-R-41    Version: 1
Type: Resolution Status: Agenda Ready
File created: 1/29/2025 In control: City Council
On agenda: 2/18/2025 Final action:
Title: A Resolution of the City Council of the City of Laredo, Texas, authorizing the City Manager to accept additional funds from the Health Resources & Services Administration 340B Drug Pricing Reimbursement Program, in the additional amount of $199,362.00, for a total amount of $499,362.00 with no match for the City of Laredo Public Health Department for the term period from October 01, 2023 through September 30, 2025. Funds will be accounted for in the Laredo Public Health Department Fund - STD 340B Program.
Attachments: 1. 2025-R-41
Date Ver.Action ByActionResultAction DetailsMeeting DetailsVideo
No records to display.

 

SUBJECT

title

A Resolution of the City Council of the City of Laredo, Texas, authorizing the City Manager to accept additional funds from the Health Resources & Services Administration 340B Drug Pricing Reimbursement Program, in the additional amount of $199,362.00, for a total amount of $499,362.00 with no match for the City of Laredo Public Health Department for the term period from October 01, 2023 through September 30, 2025. Funds will be accounted for in the Laredo Public Health Department Fund - STD 340B Program.

 

body

PREVIOUS COUNCIL ACTION

On August 05, 2024, Council approved Ordinance 2024-O-154.

 

BACKGROUND

The Health Resources & Services Administration (HRSA) 340B Program enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. Eligible health care organizations/covered entities are defined in statute and include HRSA-supported health centers and look-alikes, Ryan White clinics and State AIDS Drug Assistance programs. To participate in the 340B Program, eligible organizations and covered entities must register and be enrolled with the 340B program and comply with all 340B Program requirements. Once enrolled, covered entities are assigned a 340B identification number that vendors verify before allowing an organization to purchase 340B discounted drugs, expanding pharmaceutical access to underserved, uninsured, and low-income populations.

 

COMMITTEE RECOMMENDATION

N/A

 

STAFF RECOMMENDATION

recommendation

Staff recommends that Council approves the Resolution.

end

Fiscal Impact

 

Fiscal Year:                                                                                                          2025

Budgeted Y/N?:                                                                                    Y

Source of Funds:                                                                                     STD 340B

Account #:                                                                                                          226-6515

Change Order: Exceeds 25% Y/N:                      N/A

 

FINANCIAL IMPACT:

The revenue account 226-0000-373-2080 and the expenditure division is 226-6515 with Project Number HEMR01.